SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

EZZ EZZ Life Science Holdings Limited

Healthcare · Biotechnology · website
$0.37
52wk 0.35 – 3.38
Overall
60.6
Value
100.0
Growth
60.7
Health
100.0
Quality
0.0
Momentum
0.1
Dividend
84.5
Price
About EZZ Life Science Holdings Limited

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, South-East Asia, and internationally. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. The company was incorporated in 2015 and is based in Lidcombe, Australia.

Price analytics

Returns

1 day 0.0%
1 week -8.6%
1 month -26.0%
3 months -22.1%
6 months -56.2%
1 year -85.6%
3 years -43.1%

Risk

Volatility (1y ann.) 80.7%
Beta vs ASX 200 1.13
Sharpe (1y) -2.04
VaR 95% (1-day) -7.8%
Max drawdown (1y) -89.0%
Off 1-year high -88.9%

Technicals

RSI(14) 14 OS
vs 50DMA -20.9%
vs 200DMA -57.2%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 100.0
Trailing P/E
100
Forward P/E
100
PEG ratio
—
EV / EBITDA
100
Price / Book
100
Price / Sales
100
Growth 60.7
Revenue growth (1y)
30
Revenue CAGR (3y)
100
EPS growth (1y)
20
EPS CAGR (3y)
100
Financial Health 100.0
Net debt / EBITDA
100
Interest coverage (EBIT/interest)
100
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income 84.5
Dividend yield (%)
100
Payout ratio
68
FCF dividend cover
85
Momentum 0.1
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
0
Position in 52-week range
0

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$17.41M
P/E (trailing)
6.17
P/E (forward)
1.54
EPS (trailing)
0.06
Dividend yield
10.8%
Payout ratio
65.2%
Beta
0.96
EV / EBITDA
-1.08
Price / Book
0.71
ROE
-20.2%
Operating margin
-30.3%
Net margin
-11.5%
Total cash
$10.89M
Total debt
$478,592
Current ratio
8.70
Debt / Equity
0.02
Free cash flow
$-7.56M
Avg volume
14,614
Latest annual results (FY ending 30 Jun 2025)
  • Revenue$66.87M
  • Gross profit$49.72M
  • Operating income$9.93M
  • Net income$6.73M
  • Diluted EPS0.15
  • Free cash flow$4.09M
  • Net debt-$20.54M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4